First Horizon Advisors, Inc. Bioventus Inc. Transaction History

First Horizon Advisors, Inc.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 09, 2022	SELL	$6.54 - $9.08 $29,835 - $41,422	-4,562 Reduced 61.98%	2,798 $19,000
Q2 2022 Aug 02, 2022	BUY	$6.82 - $13.82 $50,195 - $101,715	7,360 New	7,360 $50,000

141

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $658M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on First Horizon Advisors, Inc. with notifications on news.